Comparative Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Advanced Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: Combination therapy with immune checkpoint inhibitors (ICIs) has been applied in the clinic to achieve synergistic effects and to improve clinical efficacy. Compared with monotherapy, combination therapy has promising efficacy against various advanced cancers. To further verify the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi, Jin, Gang, Pang, Yao, Huang, Yijie, Wang, Wenhao, Zhang, Hongyi, Tuo, Guangxin, Wu, Peng, Wang, Zequan, Zhu, Zijiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033417/
https://www.ncbi.nlm.nih.gov/pubmed/32116716
http://dx.doi.org/10.3389/fphar.2020.00040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033417/
https://www.ncbi.nlm.nih.gov/pubmed/32116716
http://dx.doi.org/10.3389/fphar.2020.00040

Ejemplares similares